Skip to main content

Fabrice Chouraqui, MBA, PharmD

Chief Executive Officer and Executive Director

Nationality: French national, US citizen
Date of initial appointment: March 4, 2025


Mr. Fabrice Chouraqui has been our Executive Director and Chief Executive Director (CEO) since March 2025. 

Mr. Chouraqui was appointed for a four-year term at the Extraordinary General Meeting of Shareholders (EGM) held on March 4, 2025. Mr. Chouraqui is responsible for the daily management of Pharming and the execution of our strategy.

Mr. Chouraqui is a global pharmaceutical executive with a track record of growth and value creation at Flagship Pioneering, Novartis and Bristol-Myers Squibb. He has developed experience across the business spectrum, from research and development to access and commercialization, investor management and business development. Mr. Chouraqui has led the launch of treatments in many therapeutic areas, including highly targeted specialty care drugs and large primary care medicines.

Prior to joining Pharming, Mr. Chouraqui was a CEO-Partner at Flagship Pioneering, one of the largest Biotech Venture Capital firms in the US and also served as CEO of Cellarity, Inc., one of the companies created by Flagship Pioneering. Before this, Mr. Chouraqui spent 10 years at Novartis where he was President of Novartis Pharmaceuticals USA from 2016 to 2019, President, Latin America & Canada for Novartis Pharmaceuticals from 2014 to2016, and Global Head, Business Franchise Neuroscience from 2012 to 2014. From 2000 to 2010, Mr. Chouraqui held multiple international roles at Bristol-Myers Squibb, ultimately serving as Vice President, Commercial Operations, Asia-Pacific and General Manager, Southeast Asia from 2008 to2010. He began his career in R&D roles at Roussel Uclafand Hoechst Marion Roussel, pharmaceutical companies that were predecessors to today’s Sanofi. 

Mr. Chouraqui serves as a Non-Executive Director of Cellarity and also holds the position of independent Board member of OranoMed, a non-listed (and therefore private) subsidiary of Orano Group. 

Mr. Chouraqui earned a MBA from INSEAD and a Doctorate in Pharmacy, a Post-Graduate Degree in Quality Assurance of Medicines, and a MSc in Biological and Medicinal Sciences from University of Paris V.

ABOUT USEXECUTIVE COMMITTEE | BOARD OF DIRECTORS | CORPORATE GOVERNANCE

Cookies: This website uses cookies Check the cookies page for more information Accept Decline